Satoru Aoyagi
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Satoru Aoyagi has a total of 41 co-authors. Here are the top co-authors by number of shared publications:
Hiroshi Shimizu
Department of Dermatology Hokkaido University Graduate School of Medicine Sapporo Japan
13 shared publicationsErina Homma
Department of Dermatology Hokkaido University Graduate School of Medicine Sapporo Japan
7 shared publicationsHiroo Hata
Department of Dermatology, Hokkaido University Graduate School of Medicine, Sapporo, Japan
5 shared publicationsH. Shimizu
Department of Dermatology Hokkaido University Graduate School of Medicine Sapporo Japan
3 shared publicationsH. Hata
Department of Dermatology, Hokkaido University Graduate School of Medicine, Sapporo, Japan
2 shared publications- Hideyuki Ujiie
Department of Dermatology, Faculty of Medicine and Graduate School of Medicine, Hokkaido University
2 shared publications
Latest Publications
- 2 July 2014
- Published by Wiley in The Journal of Dermatology
- Vol. 41 (7) , 656-657
Lymphangiosarcoma with strong positivity of D2‐40 and LYVE‐1 presenting different clinical features from angiosarcoma
- 2 July 2014
- Published by Wiley in The Journal of Dermatology
- Vol. 41 (7) , 656-657
Lymphangiosarcoma with strong positivity of D2‐40 and LYVE‐1 presenting different clinical features from angiosarcoma
- 24 February 2014
- Published by Wiley in The Journal of Dermatology
- Vol. 41 (4) , 316-318
Technique for histological control of surgical margins in lip cancer
To preserve oral function and achieve acceptable cosmetic results, intraoperative control of surgical margins with frozen section evaluation may help to determine surgical technique in lip cancer. However, frozen section analysis is usually limited to suspicious areas and has not been systematically performed among surgeons. The accuracy of such analysis for detecting histological surgical margins is highly dependent on the methods used to obtain and analyze the margins. Improving the pathodiagnostic reliability of conventional intraoperative frozen section evaluation is the most important goal of surgical management in our method. We describe the successful use of the “double‐blade method” in lip cancer treatment. The technique we describe has the advantage of histologically confirming clear margins in lip cancer. This method appears to be time‐saving and easy to apply with existing surgical systems. In addition, this method may be used as an alternative to complete evaluation of lateral surgical margins that is important in planning a suitable surgical reconstruction procedure in lip cancer at many institutions where Mohs micrographic surgery is difficult to perform.
- 24 February 2014
- Published by Wiley in The Journal of Dermatology
- Vol. 41 (4) , 316-318
Technique for histological control of surgical margins in lip cancer
To preserve oral function and achieve acceptable cosmetic results, intraoperative control of surgical margins with frozen section evaluation may help to determine surgical technique in lip cancer. However, frozen section analysis is usually limited to suspicious areas and has not been systematically performed among surgeons. The accuracy of such analysis for detecting histological surgical margins is highly dependent on the methods used to obtain and analyze the margins. Improving the pathodiagnostic reliability of conventional intraoperative frozen section evaluation is the most important goal of surgical management in our method. We describe the successful use of the “double‐blade method” in lip cancer treatment. The technique we describe has the advantage of histologically confirming clear margins in lip cancer. This method appears to be time‐saving and easy to apply with existing surgical systems. In addition, this method may be used as an alternative to complete evaluation of lateral surgical margins that is important in planning a suitable surgical reconstruction procedure in lip cancer at many institutions where Mohs micrographic surgery is difficult to perform.
- 25 November 2013
- Published by Wiley in Lasers in Surgery and Medicine
- Vol. 46 (2) , 132-139
Intraoperative use of spectroscopic detection of protoporphyrin IX from oral 5‐aminolevulinic acid on basal cell carcinoma and squamous cell carcinoma during Mohs surgery
- 25 November 2013
- Published by Wiley in Lasers in Surgery and Medicine
- Vol. 46 (2) , 132-139
Intraoperative use of spectroscopic detection of protoporphyrin IX from oral 5‐aminolevulinic acid on basal cell carcinoma and squamous cell carcinoma during Mohs surgery
- 13 April 2013
- Published by Wiley in Journal of the European Academy of Dermatology and Venereology
- Vol. 28 (6) , 727-732
MUC5AC expression correlates with invasiveness and progression of extramammary Paget's disease
Background: Patients with in situ extramammary Paget's disease (EMPD) tend to have a good prognosis, although dermal invasion and metastasis are associated with significantly increased morbidity and mortality. Previous studies have addressed mechanisms underlying the EMPD pathogenesis; however, no molecular markers that reflect invasiveness or progression have been established.Objective: This study aims to identify a reliable marker for predicting the risk of invasion and metastasis in EMPD.Methods: We performed an initial microarray screening for in situ, invasive or metastatic lymph node lesions of EMPD. We analysed 44 specimens from 38 primary EMPD cases by immunohistochemical staining.Results: We found that expressions of MUC5AC directly correlate with invasion and prognosis. Labelling rates of tumour cells were scored by staining intensity on a four‐tiered scale (− to 3+) to investigate the correlation between the expression score of these molecular markers and the type of EMPD lesion. All the specimens scored positive (3+) for MUC1 and negative (−) for MUC6. MUC5AC expression was detected in 19 of 44 (43.2%) specimens. Invasive lesions and metastatic lymph nodes tended to express MUC5AC significantly higher than in situ lesions (P < 0.01). MUC2 was positive in 10 specimens (22.7%). There was no significant difference between the degree of MUC2 expression and invasiveness.Conclusion: The degree of MUC5AC expression may correlate with the invasiveness and progression of EMPD, and may be a useful marker for identifying high‐risk EMPD cases.
- 13 April 2013
- Published by Wiley in Journal of the European Academy of Dermatology and Venereology
- Vol. 28 (6) , 727-732
MUC5AC expression correlates with invasiveness and progression of extramammary Paget's disease
Background: Patients with in situ extramammary Paget's disease (EMPD) tend to have a good prognosis, although dermal invasion and metastasis are associated with significantly increased morbidity and mortality. Previous studies have addressed mechanisms underlying the EMPD pathogenesis; however, no molecular markers that reflect invasiveness or progression have been established.Objective: This study aims to identify a reliable marker for predicting the risk of invasion and metastasis in EMPD.Methods: We performed an initial microarray screening for in situ, invasive or metastatic lymph node lesions of EMPD. We analysed 44 specimens from 38 primary EMPD cases by immunohistochemical staining.Results: We found that expressions of MUC5AC directly correlate with invasion and prognosis. Labelling rates of tumour cells were scored by staining intensity on a four‐tiered scale (− to 3+) to investigate the correlation between the expression score of these molecular markers and the type of EMPD lesion. All the specimens scored positive (3+) for MUC1 and negative (−) for MUC6. MUC5AC expression was detected in 19 of 44 (43.2%) specimens. Invasive lesions and metastatic lymph nodes tended to express MUC5AC significantly higher than in situ lesions (P < 0.01). MUC2 was positive in 10 specimens (22.7%). There was no significant difference between the degree of MUC2 expression and invasiveness.Conclusion: The degree of MUC5AC expression may correlate with the invasiveness and progression of EMPD, and may be a useful marker for identifying high‐risk EMPD cases.
- 14 March 2013
- Published by Wiley in International Journal of Dermatology
- Vol. 53 (2) , e126-e127
Bilateral axillary Paget’s disease: diagnostic pitfalls of dermoscopic features
- 14 March 2013
- Published by Wiley in International Journal of Dermatology
- Vol. 53 (2) , e126-e127
Bilateral axillary Paget’s disease: diagnostic pitfalls of dermoscopic features
- 21 November 2012
- Published by Wiley in International Journal of Dermatology
- Vol. 51 (12) , 1520-1522
Angiosarcoma on the lower abdominal wall associated with chronic lymphedema in an obese woman
- 21 November 2012
- Published by Wiley in International Journal of Dermatology
- Vol. 51 (12) , 1520-1522
Angiosarcoma on the lower abdominal wall associated with chronic lymphedema in an obese woman
- 12 November 2012
- Published by Wiley in Pediatric Dermatology
- Vol. 30 (5) , e83-e84
Linear Congenital Molluscum Contagiosum on the Coccygeal Region
Congenital molluscum contagiosum is rare but has been reported previously. We present a unique case of linear congenital molluscum on the coccygeal region. To make a correct diagnosis, avoid unnecessary examination, and start appropriate treatment as soon as possible, it is beneficial for dermatologists to be aware that molluscum contagiosum can present at birth and can be linear.
- 12 November 2012
- Published by Wiley in Pediatric Dermatology
- Vol. 30 (5) , e83-e84
Linear Congenital Molluscum Contagiosum on the Coccygeal Region
Congenital molluscum contagiosum is rare but has been reported previously. We present a unique case of linear congenital molluscum on the coccygeal region. To make a correct diagnosis, avoid unnecessary examination, and start appropriate treatment as soon as possible, it is beneficial for dermatologists to be aware that molluscum contagiosum can present at birth and can be linear.
- 23 June 2012
- Published by Wiley in The Journal of Dermatology
- Vol. 39 (12) , 1044-1046
Efficacy of N‐(3,4‐dimethoxycinnamoyl)‐anthranilic acid (tranilast) against eruptive syringoma: Report of two cases and review of published work
- 23 June 2012
- Published by Wiley in The Journal of Dermatology
- Vol. 39 (12) , 1044-1046
Efficacy of N‐(3,4‐dimethoxycinnamoyl)‐anthranilic acid (tranilast) against eruptive syringoma: Report of two cases and review of published work
- 15 March 2012
- Published by S. Karger AG in Oncology
- Vol. 82 (3) , 139-146
Sequential Local Injection of Low-Dose Interferon-Beta for Maintenance Therapy in Stage II and III Melanoma: A Single-Institution Matched Case-Control Study
Objective: To determine the beneficial effect of maintenance therapy in stage II and III melanoma by sequential local injection of low-dose interferon-β. Methods: We reviewed 46 patients with stage II and III primary melanoma at our institution from 2004 through 2009. Twenty-one patients were treated with interferon-β maintenance therapy consisting of subcutaneous injection of natural interferon-β at a dose of 3 × 106 IU/day for 10 consecutive days, and 25 patients underwent observation alone. Results: Compared with all patients, overall survival and relapse-free survival were significantly worse in the observation group than in the interferon-β group (p = 0.024 and 0.029, respectively). In stage II, a significant difference in overall survival, but not in relapse-free survival, was seen between the two groups (p = 0.041). When the interferon-β group was stratified by subgroup, there was a statistical difference only between dosage and duration (p = 0.027 and p < 0.001, respectively). Conclusions: This study demonstrates that maintenance therapy by interferon-β is beneficial in the outcome of the disease without substantial toxic effects, especially in patients with stage II melanoma. Extension of the duration of treatment beyond 2 years could further improve the therapeutic efficacy of interferon-β.
- 15 March 2012
- Published by S. Karger AG in Oncology
- Vol. 82 (3) , 139-146
Sequential Local Injection of Low-Dose Interferon-Beta for Maintenance Therapy in Stage II and III Melanoma: A Single-Institution Matched Case-Control Study
Objective: To determine the beneficial effect of maintenance therapy in stage II and III melanoma by sequential local injection of low-dose interferon-β. Methods: We reviewed 46 patients with stage II and III primary melanoma at our institution from 2004 through 2009. Twenty-one patients were treated with interferon-β maintenance therapy consisting of subcutaneous injection of natural interferon-β at a dose of 3 × 106 IU/day for 10 consecutive days, and 25 patients underwent observation alone. Results: Compared with all patients, overall survival and relapse-free survival were significantly worse in the observation group than in the interferon-β group (p = 0.024 and 0.029, respectively). In stage II, a significant difference in overall survival, but not in relapse-free survival, was seen between the two groups (p = 0.041). When the interferon-β group was stratified by subgroup, there was a statistical difference only between dosage and duration (p = 0.027 and p < 0.001, respectively). Conclusions: This study demonstrates that maintenance therapy by interferon-β is beneficial in the outcome of the disease without substantial toxic effects, especially in patients with stage II melanoma. Extension of the duration of treatment beyond 2 years could further improve the therapeutic efficacy of interferon-β.
- 10 November 2011
- Published by Springer Nature
- p. 503-508
International Perspective of Mohs Micrographic Surgery: East Asia
- 10 November 2011
- Published by Springer Nature
- p. 503-508
International Perspective of Mohs Micrographic Surgery: East Asia